Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2011 3
2012 2
2013 4
2014 9
2015 5
2016 9
2017 5
2018 3
2019 3
2020 3
2021 7
2022 2
Text availability
Article attribute
Article type
Publication date

Search Results

48 results
Results by year
Filters applied: . Clear all
Page 1
Historically controlled comparison of glucocorticoids with or without tocilizumab versus supportive care only in patients with COVID-19-associated cytokine storm syndrome: results of the CHIC study.
Ramiro S, Mostard RLM, Magro-Checa C, van Dongen CMP, Dormans T, Buijs J, Gronenschild M, de Kruif MD, van Haren EHJ, van Kraaij T, Leers MPG, Peeters R, Wong DR, Landewé RBM. Ramiro S, et al. Among authors: magro checa c. Ann Rheum Dis. 2020 Sep;79(9):1143-1151. doi: 10.1136/annrheumdis-2020-218479. Epub 2020 Jul 20. Ann Rheum Dis. 2020. PMID: 32719045 Free PMC article. Clinical Trial.
2021 update of the EULAR points to consider on the use of immunomodulatory therapies in COVID-19.
Alunno A, Najm A, Machado PM, Bertheussen H, Burmester GR, Carubbi F, De Marco G, Giacomelli R, Hermine O, Isaacs JD, Koné-Paut I, Magro-Checa C, McInnes IB, Meroni PL, Quartuccio L, Ramanan AV, Ramos-Casals M, Rodríguez Carrio J, Schulze-Koops H, Stamm TA, Tas SW, Terrier B, McGonagle DG, Mariette X. Alunno A, et al. Among authors: magro checa c. Ann Rheum Dis. 2022 Jan;81(1):34-40. doi: 10.1136/annrheumdis-2021-221366. Epub 2021 Oct 7. Ann Rheum Dis. 2022. PMID: 34620584 Free PMC article.
Calcium pyrophosphate crystal deposition disease: diagnosis and treatment.
Rosales-Alexander JL, Balsalobre Aznar J, Magro-Checa C. Rosales-Alexander JL, et al. Among authors: magro checa c. Open Access Rheumatol. 2014 May 8;6:39-47. doi: 10.2147/OARRR.S39039. eCollection 2014. Open Access Rheumatol. 2014. PMID: 27790033 Free PMC article. Review.
Demyelinating disease in SLE: is it multiple sclerosis or lupus?
Magro Checa C, Cohen D, Bollen EL, van Buchem MA, Huizinga TW, Steup-Beekman GM. Magro Checa C, et al. Best Pract Res Clin Rheumatol. 2013 Jun;27(3):405-24. doi: 10.1016/j.berh.2013.07.010. Best Pract Res Clin Rheumatol. 2013. PMID: 24238696 Review.
Tocilizumab in Severe COVID-19 Pneumonia and Concomitant Cytokine Release Syndrome.
van Kraaij TD, Mostard RL, Ramiro S, Magro Checa C, van Dongen CM, van Haren EH, Buijs J, Landewé RB. van Kraaij TD, et al. Among authors: magro checa c. Eur J Case Rep Intern Med. 2020 Apr 22;7(5):001675. doi: 10.12890/2020_001675. eCollection 2020. Eur J Case Rep Intern Med. 2020. PMID: 32399455 Free PMC article.
EULAR points to consider on pathophysiology and use of immunomodulatory therapies in COVID-19.
Alunno A, Najm A, Machado PM, Bertheussen H, Burmester GR, Carubbi F, De Marco G, Giacomelli R, Hermine O, Isaacs JD, Koné-Paut I, Magro-Checa C, McInnes I, Meroni PL, Quartuccio L, Ramanan AV, Ramos-Casals M, Rodríguez Carrio J, Schulze-Koops H, Stamm TA, Tas SW, Terrier B, McGonagle DG, Mariette X. Alunno A, et al. Among authors: magro checa c. Ann Rheum Dis. 2021 Jun;80(6):698-706. doi: 10.1136/annrheumdis-2020-219724. Epub 2021 Feb 5. Ann Rheum Dis. 2021. PMID: 33547062 Free PMC article.
Recurrent parotid pseudogout.
Rosales Alexander JL, Magro Checa C, Salvatierra J, Caba Molina M, Raya Álvarez E. Rosales Alexander JL, et al. Among authors: magro checa c. Rheumatology (Oxford). 2012 Dec;51(12):2169. doi: 10.1093/rheumatology/kes265. Epub 2012 Oct 1. Rheumatology (Oxford). 2012. PMID: 23033502 No abstract available.
48 results